Tang CK - Search Results

1

Involvement of heregulin-beta2 in the acquisition of the hormone-independent phenotype of breast cancer cells.

Tang CK, Perez C, Grunt T, Waibel C, Cho C, Lupu R. Tang CK, et al. Cancer Res. 1996 Jul 15;56(14):3350-8. Cancer Res. 1996. PMID: 8764133

2

The significance of heregulin in breast cancer tumor progression and drug resistance.

Lupu R, Cardillo M, Cho C, Harris L, Hijazi M, Perez C, Rosenberg K, Yang D, Tang C. Lupu R, et al. Breast Cancer Res Treat. 1996;38(1):57-66. doi: 10.1007/BF01803784. Breast Cancer Res Treat. 1996. PMID: 8825123 Review.

3

Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.

Harris LN, Yang L, Tang C, Yang D, Lupu R. Harris LN, et al. Clin Cancer Res. 1998 Apr;4(4):1005-12. Clin Cancer Res. 1998. PMID: 9563896

4

Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.

Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C, Lupu R. Atlas E, et al. Mol Cancer Res. 2003 Jan;1(3):165-75. Mol Cancer Res. 2003. PMID: 12556556 Free article.

5

Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.

Hijazi MM, Thompson EW, Tang C, Coopman P, Torri JA, Yang D, Mueller SC, Lupu R. Hijazi MM, et al. Int J Oncol. 2000 Oct;17(4):629-41. doi: 10.3892/ijo.17.4.629. Int J Oncol. 2000. PMID: 10995872

6

Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer.

Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R. Tsai MS, et al. Among authors: tang ck. Oncogene. 2003 Feb 6;22(5):761-8. doi: 10.1038/sj.onc.1206130. Oncogene. 2003. PMID: 12569369

7

Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.

Yang X, Wei LL, Tang C, Slack R, Mueller S, Lippman ME. Yang X, et al. Cancer Res. 2001 Jul 1;61(13):5284-8. Cancer Res. 2001. PMID: 11431371

8

Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo.

Tang CK, Concepcion XZ, Milan M, Gong X, Montgomery E, Lippman ME. Tang CK, et al. Cancer Res. 1999 Oct 15;59(20):5315-22. Cancer Res. 1999. PMID: 10537315

9

Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.

Tang CK, Gong XQ, Moscatello DK, Wong AJ, Lippman ME. Tang CK, et al. Cancer Res. 2000 Jun 1;60(11):3081-7. Cancer Res. 2000. PMID: 10850460

10

Suppression of EGFRvIII-mediated proliferation and tumorigenesis of breast cancer cells by ribozyme.

Luo X, Gong X, Tang CK. Luo X, et al. Among authors: tang ck. Int J Cancer. 2003 May 10;104(6):716-21. doi: 10.1002/ijc.11007. Int J Cancer. 2003. PMID: 12640678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters